BRIEF-Medicus Pharma Ltd To Acquire Antev Ltd. For $75 Million In A Share Exchange Transaction-March 2024-www.financetom.com

BRIEF-Medicus Pharma Ltd To Acquire Antev Ltd. For $75 Million In A Share Exchange Transaction

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Medicus Pharma Ltd To Acquire Antev Ltd. For $75 Million In A Share Exchange Transaction

May 25, 2025 9:39 PM

Medicus Pharma Ltd ( MDCX ):

* MEDICUS PHARMA LTD ( MDCX ): TO ACQUIRE ANTEV LTD. FOR $75 MILLION

IN A

SHARE EXCHANGE TRANSACTION

* MEDICUS PHARMA ( MDCX ): ANTEV SHAREHOLDERS TO RECEIVE ABOUT 19%

STAKE

IN MEDICUS AND $65 MILLION IN CONTINGENT PAYMENTS

Source text:

Further company coverage:

Previous page： NetApp to Be Primary Data Storage Vendor of Anaplan Next page： --Johnson Controls Maintains Dividend at $0.37 per Share, Payable Oct. 18 to Shareholders of Record on Sept. 25

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

NetApp to Be Primary Data Storage Vendor of Anaplan

Sep 11, 2024

10:25 AM EDT, 09/11/2024 (MT Newswires) -- NetApp ( NTAP ) said Wednesday it will be the primary data storage vendor of Anaplan, which provides a platform for business planning and decision-making. The move is part of Anaplan's decision to consolidate the storage of its public and private cloud deployments. Financial terms were not disclosed. NetApp ( NTAP ) shares...

--Johnson Controls Maintains Dividend at $0.37 per Share, Payable Oct. 18 to Shareholders of Record on Sept. 25

Sep 11, 2024

09:08 AM EDT, 09/11/2024 (MT Newswires) -- Price: 69.65, Change: -0.69, Percent Change: -0.98 ...

Weight-loss market to see 16 new drugs by 2029, report estimates

Sep 11, 2024

(Reuters) - The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business currently dominated by Novo Nordisk and Eli Lilly ( LLY ), according to estimates from analysts at Morningstar and Pitchbook. In a joint report published on Monday, analysts estimated the market for obesity treatments could expand to $200...

Business groups fear political pressure influencing US review of Nippon

Sep 11, 2024

Sept 11 (Reuters) - A number of U.S. business groups on Wednesday sounded the alarm that the Biden administration's national security review of Nippon Steel's ( NISTF ) planned $14.9 billion acquisition of U.S. Steel is being unduly influenced by political pressure. The Committee on Foreign Investment in the United States (CFIUS) told the companies in an Aug. 31 letter...